Anti-histone antibodies in rheumatoid arthritis
Youinou, P.; Brousse, A.; Le Goff, P.
Revue du Rhumatisme et des Maladies Osteo-Articulaires 51(7-8): 419-420
1984
ISSN/ISBN: 0035-2659 PMID: 6333712 Document Number: 231491
Document emailed within 1 workday
Related Documents
Wakhlu, A.; Gupta, D.; Aggarwal, A.; Misra, R. 2003: Low levels of anti-histone antibodies in north Indian children with juvenile rheumatoid arthritis Indian Journal of Medical Research 118: 204-207Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Tang, F.L.; Dong, Y.; Chang, P.Z. 1990: Detection and clinical significance of anti-histone antibody in systemic lupus erythematosus and rheumatoid arthritis Zhonghua Nei Ke Za Zhi 29(4): 221-223; 253
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Breedveld, F.C.; de Vries, R.R. 1992: Anti-CD4 antibodies in rheumatoid arthritis Clinical and Experimental Rheumatology 10(4): 325-326
Hayashi, N.; Kumagai, S. 2010: Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 58(5): 466-479
Toes, R.E.; van der Woude, D. 2011: ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis Acta Reumatologica Portuguesa 36(3): 205-207
Heurkens, A.H.; Hiemstra, P.S.; Lafeber, G.J.; Daha, M.R.; Breedveld, F.C. 1989: Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis Clinical and Experimental Immunology 78(1): 7-12
Wanchu, A.; Deodhar, S.D.; Sharma, M.; Gupta, V.; Bambery, P.; Sud, A. 1997: Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis Indian Journal of Medical Research 105: 39-42
Ramírez, Súl.; Ramírez, Mía.G.; Muñoz, Jé.F.; Martínez, G.E.; Velarde, E.E.; Sánchez, P.E. 2019: Association of KIR2DL2 gene with anti-cyclic citrullinated protein antibodies for serodiagnosis in rheumatoid arthritis Medicina 79(3): 161-166
Caro-Oleas, J.L.; Fernández-Suárez, A.; Reneses Cesteros, S.; Porrino, C.; Núñez-Roldán, A.; Wichmann Schlipf, I. 2008: Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up Clinical and Experimental Rheumatology 26(3): 461-463
Awwad, H.M.; Aboukhamis, I.A. 2010: Diagnostic Performances of Anti-Cyclic Citrullinated Peptide Antibodies type IgM, IgA and IgG in Syrian Patients with Rheumatoid Arthritis Clinical Laboratory 56(3-4): 95-102
Lequerré, T.; Richez, C. 2012: Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis La Revue du Praticien 62(8): 1088-1089
Shoenfeld, Y.; Segol, O. 1989: Anti-histone antibodies in SLE and other autoimmune diseases Clinical and Experimental Rheumatology 7(3): 265-271
Ferec, C.; Youinou, P.; Le Goff, P.; Miossec, P.; Morin, J.F.; Pennec, Y.; Morin, P.P.; Le Menn, G. 1984: Significance of antinuclear anti-histone antibodies Annales de Medecine Interne 135(6): 427-430
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Punzi, L.; di Maggio, C.; Mazzi, A.; Presacco, D.; Ruffatti, A.; Pellegrini, A.; Todesco, S. 1987: Radiological lesions of the hands in rheumatoid arthritis with rheumatoid factors and antinuclear antibodies Revue du Rhumatisme et des Maladies Osteo-Articulaires 54(7-9): 563-566
Vischer, T.L.; Jeannet, M. 1986: Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors Clinical and Experimental Rheumatology 4(2): 139-142
Chen, C.S.; Shi, G.Y. 1994: Detection of serum anti-histone antibodies in patients with ankylosing spondylitis and its clinical significance Zhonghua Nei Ke Za Zhi 33(6): 382-384
Johnston, S.L.; Runge, L.A.; Johnson, J.L.; Phillips, P.E. 1985: Specificity of antibodies in rheumatoid arthritis. I. a controlled study of humoral antibodies to bovine nasal cartilage components Clinical and Experimental Rheumatology 3(3): 221-227